Anteilseigner
OrbiMed Advisors Private Equity (16,08 %) RA Capital Management LP (9,54 %) Novo Holdings A/ S (Investment Company) (6,79 %) Baker Bros. Advisors LP (6,25 %) Fidelity Management & Research Co. LLC (5,83 %) BlackRock Fund Advisors (5,00 %) The Vanguard Group, Inc. (4,22 %) Viking Global Investors LP (3,57 %) Frazier Life Sciences Management LP (3,54 %) Cormorant Asset Management LP (3,22 %) Deerfield Management Co. LP (Private Equity) (3,08 %) Citadel Advisors LLC (2,91 %) Paradigm BioCapital Advisors LP (2,62 %) Perceptive Advisors LLC (2,48 %) TCG Crossover Management LLC (2,43 %) Venrock Associates (1,95 %) Janus Henderson Investors US LLC (1,93 %) Goldman Sachs & Co. LLC (Private Banking) (1,80 %) New Leaf Venture Partners LLC (1,66 %) Geode Capital Management LLC (1,47 %)
Kontakt
Edgewise Therapeutics Inc.